Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxysafflor yellow A injection vs Dengzhanxixin for acute atherosclerotic thrombotic cerebral infarction
CTR20150839Phase 3Suspended
- Sponsor
- Tiansanqi
- Start
- Jan 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxysafflower yellow a in brain infarction, ischemic stroke, sponsored by Tiansanqi. Started Jan 2016; status: suspended.
02
Drugs
hydroxysafflower yellow a
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on CTR20150839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150839.